embody vs Medvi vs wellmedr: $69, $99 or $59?
Last updated: Aug 28, 2026
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
Here’s the short version
This trio is unusual: all three carry a verified Trustpilot record, so for once the review data can carry as much weight as the price tag. wellmedr is the cheapest at $59/month - a rate that locks on a 12-month plan - and holds the highest rating here, 4.7 across 1,205 reviews. embody's $69 is flat with zero commitment and a refund if a provider doesn't approve you, at 3.8 across 4,956 reviews. Medvi's $99 promo is the all-inclusive, high-touch option - video visits, free dietician, care coaching - with the largest review base of the three: 4.4 across 14,372.
embody vs Medvi vs wellmedr: side by side
Real published prices and terms - the differences that actually decide this matchup.
| embody | Medvi | wellmedr | |
|---|---|---|---|
| Semaglutide | $69/mo, flat at every dose | $99/mo promo (reg. $199), all-inclusive | $59/mo (12-month plan), same price at every dose |
| Tirzepatide | $119/mo | $166/mo promo (reg. $299) | $99/mo |
| Billing & commitment | Monthly - no commitment, cancel anytime | Monthly, all-inclusive - no surprise charges; HSA/FSA approved | Monthly billing - best rate locks on a 12-month plan |
| Shipping | Free 1-2 day, tracked & insured | Free shipping | Free, every 4 weeks, discreet packaging |
| Support | Licensed doctors, medical director & nursing team | Video visits + free dietician & care coaching | Medical Weight-Care Coach on every plan |
| Guarantee / refund | Full refund if you're not approved | - | Weight-loss warranty (terms on site) |
| Standout | LegitScript-certified; 503A pharmacies | 4.4 on Trustpilot across 14,372 reviews | 1M+ patients; board-certified specialists |
Our verdict
Decide on commitment first, support second. Ready to commit to a year: wellmedr - the $59 lock is the best per-month rate in the market, its 4.7 rating is the highest here, and its weight-loss warranty backs the plan. Not ready to commit to anything: embody - $69 flat, cancel anytime, refunded if not approved. Know from experience that you quit without someone checking in: Medvi - the $30 premium over embody buys video visits, a dietician and coaching, and 14,372 reviews averaging 4.4 say that model holds up at scale. All three prescribe the same compounded semaglutide after a licensed-provider review.
embody vs Medvi vs wellmedr: FAQs
Which is cheapest: embody, Medvi or wellmedr?
For compounded semaglutide: wellmedr at $59/month (the rate locks on a 12-month plan), embody at $69/month flat with no commitment, Medvi at $99/month promotional (regularly $199) all-inclusive. For tirzepatide: wellmedr $99, embody $119, Medvi $166 promotional (regularly $299).
Which has the best Trustpilot rating?
wellmedr holds the highest rating of the three - 4.7 across 1,205 reviews. Medvi has the largest verified base: 4.4 across 14,372 reviews. embody sits at 3.8 across 4,956. All three figures are the providers' live Trustpilot aggregates at our last verification.
Which is best if I don't want a commitment?
embody - $69/month flat, billed month to month, cancel anytime, and a full refund if a licensed provider doesn't approve you for treatment. Medvi also bills monthly with no prepaid term. wellmedr's best rate ($59) requires a 12-month plan.
Do any of the three offer a guarantee?
wellmedr backs treatment with a weight-loss warranty (terms on its site), and embody refunds you in full if you're not approved. Medvi doesn't advertise a results guarantee - its pitch is the all-inclusive support model instead.
Break it down two at a time
The head-to-head comparisons between these providers.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)